


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.06%
+0.13%
-1.83%
-0.30%
-2.07%
WST
West Pharmaceutical
$241.78
Strengths

Earnings are forecast to grow

Pays a reliable dividend
WST Price Performance
$279.41 (-13.47%)
$260.14 (-7.06%)
$252.22 (-4.14%)
$232.34 (+4.06%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Pays a reliable dividend
Future
Future

Earnings are forecast to grow
![]()
WST Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
WST Street Sentiment is extremely bullish and have positive views on the near-term outlook
WST has Low risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Jan 22, 2026
Upgrade
Buy
Zacks
Nov 04, 2025
Initiate
Buy
TD Cowen
Oct 30, 2025
Initiate
Buy
TD Cowen
Oct 25, 2025
Reiterate
Buy
UBS
Oct 25, 2025
Reiterate
Overweight
KeyBanc
What is WST current stock price?
What are WST stock strengths?
What is WST Risk Level?
What is WST market cap and volume?
What is WST current Stock IQ?
Should I buy WST stock right now?
Is WST a Strong Buy right now?
What does a 'Strong Buy' rating mean for WST?
What does a 'Strong Sell' rating mean for WST?
What factors influence WST's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+1.06%
+0.13%
-1.83%
-0.30%
-2.07%
WST
West Pharmaceutical
Current Price
$241.78

WST Price Performance
$279.41 (-13.47%)
$260.14 (-7.06%)
$252.22 (-4.14%)
$232.34 (+4.06%)
WST Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Pays a reliable dividend
Future
Future

Earnings are forecast to grow
![]()
WST Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
WST Street Sentiment is extremely bullish and have positive views on the near-term outlook
WST has Low risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Jan 22, 2026
Upgrade
Buy
Zacks
Nov 04, 2025
Initiate
Buy
TD Cowen
Oct 30, 2025
Initiate
Buy
TD Cowen
Oct 25, 2025
Reiterate
Buy
UBS
Oct 25, 2025
Reiterate
Overweight
KeyBanc
WST Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Pays a reliable dividend
WST Latest Analysis
West Pharmaceutical Q4 Earnings Rise. Guides FY26 . (RTTNews) - West Pharmaceutical Services Inc. (WST) on Thursday reported its higher net income in the fourth quarter compared with the previous year and issued an outlook for the full year 2026.
Today
West Reports Fourth-Quarter and Full-Year 2025 Results. – Strong 4Q results driven by double-digit organic revenue growth in HVP Components – – Introduces Fiscal 2026 Financial Guidance – EXTON Pa. Feb. 12 2026 /PRNewswire/ -- West Pharmaceutical Services Inc. (NYSE: WST) a leading provider of innovative high-quality injectable...
Today
Countdown to West Pharmaceutical (WST) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS. Looking beyond Wall Streets top-and-bottom-line estimate forecasts for West Pharmaceutical (WST) delve into some of its key metrics to gain a deeper insight into the companys potential performance for the quarter ended December 2025.
Tue Feb 10, 2026
West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?. West Pharmaceutical (WST) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thu Feb 5, 2026
Heres Why West Pharmaceutical (WST) Is a Great Buy the Bottom Stock Now. West Pharmaceutical (WST) appears to have found support after losing some value lately as indicated by the formation of a hammer chart. In addition to this technical chart pattern strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stocks potential for a turnaround in the near term.
Fri Jan 30, 2026
Ex-Dividend Reminder: West Pharmaceutical Services Heritage Financial and Entegris . Looking at the universe of stocks we cover at Dividend Channel on 1/28/26 West Pharmaceutical Services Inc. (Symbol: WST) Heritage Financial Corp (Symbol: HFWA) and Entegris Inc (Symbol: ENTG) will all trade ex-dividend for their respective upcoming dividends. West Pharmace
Mon Jan 26, 2026
WST Launches Synchrony S1 Prefillable Syringe at Pharmapack. West Pharmaceutical debuts the Synchrony S1 prefillable syringe at Pharmapack 2026 enhancing biologics vaccines and home-care support.
Fri Jan 23, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.